Skip to Main Content

Paper Details

Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.
Cancer Discov
29
2018
AKT3, ESR1, Gene Fusions, HR+, HR+ breast cancer, Hormone, Hormone Receptor, Hormone Receptor-Positive Breast Cancer, PIK3CA, RAF1, advanced, breast cancer, driver genes, estrogen, expressed gene, gene fusions, hormone receptor, hormone receptor-positive (HR+) breast cancer, intergenic, intergenic fusions, nontransformed cells, patients, primary, tumors
Author NameAffiliation
Nora HorickMassachusetts General Hospital
Dianne M FinkelsteinHarvard Medical School
Dianne M FinkelsteinMassachusetts General Hospital
Aditya BardiaMassachusetts General Hospital Cancer Center
Aditya BardiaHarvard Medical School
Dennis C SgroiHarvard Medical School
Dennis C SgroiMassachusetts General Hospital
Anthony J IafrateHarvard Medical School
Anthony J IafrateMassachusetts General Hospital
  • 1 - 9

Datasets

Release 1.2